Our team
Glysantis is led by experienced executives with a track record of building and scaling science‑based organizations, and is supported by key academic and knowledge partnerships.
Management
Board of Directors
Former CEO of Immunovaccine, Shire Biologics, Connaught Laboratories, and North American Vaccine, Inc.
Former SVP at Glaxo
Former VP of Amgen,
AstraZeneca and Gilead
Professor and Chief of Rheumatology, University of Washington
Former CEO, Pelican Therapeutics
Wall Street Biotech Analyst
Independent Pharma Advisor
CEO, Glysantis
Former CEO, Mirexus Biotechnologies
CEO, EnerWorks
CEO, Energy Visions
VP Scientific Operations, Virica Biotech Inc.
Former R&D Director, Glysantis
Scientific Partners
Professor and Tier 1 Canada Research Chair, Biomedical Sciences, University of Guelph
Professor and Research Chair, Health Sciences, Wilfrid Laurier University
Professor and Research Chair in Novel Sustainable Nanomaterials, University of Guelph
Professor and Vice-Chair for Research, Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School